Bristol Myers Squibb Stock Story
BMY Stock | USD 54.23 0.98 1.84% |
Slightly above 51% of Bristol Myers' investor base is interested to short. The analysis of overall sentiment of trading Bristol Myers Squibb stock suggests that many investors are impartial at this time. Bristol Myers' investor sentiment overview provides quick insight into current market opportunities from investing in Bristol Myers Squibb. The current market sentiment, together with Bristol Myers' historical and current headlines, can help investors time the market. In addition, many technical investors use Bristol-Myers Squibb stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Bristol Myers stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Bristol daily returns and investor perception about the current price of Bristol Myers Squibb as well as its diversification or hedging effects on your existing portfolios.
Bristol |
Requested story not found. it has been either deleted or moved. View all stories for Bristol Myers Squibb.
Bristol Myers Latest Timeline
Bristol-Myers Squibb is traded for 54.23. About 79.0% of the company shares are held by institutions such as insurance companies. The book value of Bristol Myers was currently reported as 14.56. The company has Price/Earnings To Growth (PEG) ratio of 2.42. Bristol-Myers Squibb last dividend was issued on the 4th of April 2024. The entity had 1000000:95 split on the 7th of August 2001.Check out Bristol Myers Hype Analysis, Bristol Myers Correlation and Bristol Myers Performance. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Bristol Stock analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Transaction History View history of all your transactions and understand their impact on performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is Bristol Myers' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.09) | Dividend Share 2.31 | Earnings Share 3.93 | Revenue Per Share 21.753 | Quarterly Revenue Growth 0.006 |
The market value of Bristol-Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.